v3.25.2
Note 21 - Non-controlling Interests - Summary of Income Statement Information (Details) - USD ($)
$ in Thousands
 12 Months Ended
May 31, 2025
May 31, 2024
May 31, 2023
Net loss $ (2,181,356) $ (222,404) $ (1,443,000)
Other comprehensive (loss) income 430 3,121 (8,356)
Net comprehensive (loss) income (2,180,926) (219,283) (1,451,356)
Comprehensive (loss) income attributable to NCI 5,376 22,587 27,146
Additional income attributable to NCI 0    
Subsidiaries [Member]      
Revenue 78,414 103,331 161,580
Total expenses 74,575 82,349 250,798
Net loss 3,839 20,982 (89,218)
Other comprehensive (loss) income (49) (172) 35,153
Net comprehensive (loss) income 3,790 20,810 (54,065)
Comprehensive (loss) income attributable to NCI 5,376 17,251 15,725
Additional income attributable to NCI   5,336 11,421
Net comprehensive (loss) income attributable to NCI 5,376 22,587 27,146
Superhero Acquisition LP [Member]      
Revenue 0 0 0
Total expenses 20,000 42,681 107,297
Net loss (20,000) (42,681) (107,297)
Other comprehensive (loss) income 0 0 70,778
Net comprehensive (loss) income $ (20,000) $ (42,681) $ (36,519)
Non-controlling interest % 32.00% 32.00% 32.00%
Comprehensive (loss) income attributable to NCI $ (6,400) $ (13,658) $ (11,686)
Additional income attributable to NCI   0 0
Net comprehensive (loss) income attributable to NCI (6,400) (13,658) (11,686)
CC Pharma Nordic ApS [Member]      
Revenue 0 0 126
Total expenses 11 (1,064) 748
Net loss (11) 1,064 (622)
Other comprehensive (loss) income 8 (9) (21)
Net comprehensive (loss) income $ (3) $ 1,055 $ (643)
Non-controlling interest % 25.00% 25.00% 25.00%
Comprehensive (loss) income attributable to NCI $ (1) $ 264 $ (161)
Additional income attributable to NCI   0 0
Net comprehensive (loss) income attributable to NCI (1) 264 (161)
Aphria Diamond [Member]      
Revenue 78,414 103,331 161,453
Total expenses 54,274 40,935 85,460
Net loss 24,140 62,396 75,993
Other comprehensive (loss) income (45) 171 (961)
Net comprehensive (loss) income $ 24,095 $ 62,567 $ 75,032
Non-controlling interest % 49.00% 49.00% 49.00%
Comprehensive (loss) income attributable to NCI $ 11,807 $ 30,658 $ 36,766
Additional income attributable to NCI   5,336 11,421
Net comprehensive (loss) income attributable to NCI 11,807 35,994 48,187
ColCanna S.A.S. [Member]      
Revenue 0 0 1
Total expenses 290 (203) 57,293
Net loss (290) 203 (57,292)
Other comprehensive (loss) income (12) (334) (34,643)
Net comprehensive (loss) income $ (302) $ (131) $ (91,935)
Non-controlling interest % 10.00% 10.00% 10.00%
Comprehensive (loss) income attributable to NCI $ (30) $ (13) $ (9,194)
Additional income attributable to NCI   0 0
Net comprehensive (loss) income attributable to NCI $ (30) $ (13) $ (9,194)